India�s Gennova Working On Omicron-Specific COVID-19 Vaccine � Source
[email protected]24 Feb, 2022News
India?s Gennova Biopharmaceuticals is working on an Omicron-specific COVID-19 vaccine candidate that could be ready in a month or two, a person with direct knowledge of the matter told Reuters. The source, who did not want to be named as the information was private, said the product might need a small trial in India before it could be rolled out as a booster or standalone vaccine. A representative for Gennova, a unit of drugmaker Emcure Pharmaceuticals that does business in some 70 countries, did not immediately respond to a request for comment.
Related Bookmarks
- India's Gennova Working On Omicron-Specific COVID-19 Vaccine
- Pune-Based Gennova Biopharmaceuticals Developing Vaccine For Omicron: Why This Could Be A Game Chang
- Preschool Corte Madera
- Shared Services operate with a mindset of a business and views other organizations as customers
- Valves are devices that regulate the flow of fluids by opening and closing
- Apple Unterst�tzung Berlin
- Get the Benefits For Garage Door Repair in Markham
- Antimicrobial Additives are antimicrobial agents that inhibit and prevent germs
- Peer-to-peer lending is an alternative to traditional banks
- Kia Carens Specifications
Recent Profiles
Nhà Cái 58win
Cleo Chaya
Artixan Modulars Llp
79king
Topbet
Crossed Arrow Earthworks, Llc
Nsfwai
Gahrïelle Design Studio
Singleton Head
Cassidy Kline